Connect with us

Hi, what are you looking for?

OTC Markets:RHHBY

#results #STRONGHF #study #show #clear #advantages The primary endpoints of the STRONG-HF study demonstrated a significant reduction in death from all causes or readmissions...

OTC Markets:RHHBY

#Roche #receives #FDA #clearance #COVID19 #PCR #test The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated,...

OTC Markets:RHHBY

#Roche #present #OCREVUS #ocrelizumab #data #multiple OCREVUS data will show significant benefit on slowing disease activity and progression in patients with treatment-naive early-stage relapsing-remitting...